Irish Biotech Startup Aerska Secures $21M to Push Boundaries of Brain RNAi Therapies
Aerska, a newly formed biotechnology company focused on transforming the treatment of neurological diseases, has officially launched with $21 million
Read moreAerska, a newly formed biotechnology company focused on transforming the treatment of neurological diseases, has officially launched with $21 million
Read moreAstraZeneca, the Anglo-Swedish pharmaceutical giant, announced on Monday, plans to harmonise its share listing structure across the London Stock Exchange
Read moreBristol Myers Squibb has added a premier radiopharmaceutical platform to its portfolio with the acquisition of RayzeBio, a radiopharmaceutical therapeutics
Read moreThe U.S. Food and Drug Administration (FDA) has approved a second COVID-19 vaccine developed by Moderna, which will be marketed
Read moreEvotec, a publicly listed drug discovery and development company, has won a € 7.5 million grant for the development of
Read moreValneva shares dropped by around 40% in early trading on Monday as the UK government announced its intention to withdraw
Read moreThe announced temporary waiver of COVID-19 vaccine patents by Joe Biden’s administration has hit vaccine maker shares and raised serious
Read moreEvotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) revealed that it has invested in OxVax, a new immuno-oncology organization
Read morePhico Therapeutics (‘Phico’), a British biotech company developing engineered phage technologies as the foundation of a new wave of antibiotics
Read moreThermo Fisher Scientific expands clinical research service offering to pharma and biotech customers with a CRO giant PPD acquisition. Thermo
Read more